i-SEP is a Medtech based in Nantes (Upper Brittany, France) focusing on IntraOperative Cell Salvage (IOCS) or Autotransfusion and Patient Blood Management (PBM).
i-SEP has developed and markets a patented innovative technology for the separation of blood components.
i-SEP markets a new generation of IntraOperative Cell Salvage technology (IOCS) for use in hemorrhagic or high-risk hemorrhagic surgery, capable of recovering not only red blood cells but also the patient’s platelets.